Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
Lectin pathway of complement activation | Rattus norvegicus |
Lectin pathway of complement activation | Homo sapiens |
Lectin pathway of complement activation | Canis familiaris |
Lectin pathway of complement activation | Sus scrofa |
Lectin pathway of complement activation | Bos taurus |
Lectin pathway of complement activation | Mus musculus |
Lectin pathway of complement activation | Gallus gallus |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
33651246 | The role of posttranslational modification in moonlighting glyceraldehyde-3-phosphate dehydrogenase structure and function | Sirover MA | 2021 Mar 02 |
|
33655252 | Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants | Wang L | 2021 Mar 01 |
|
35423449 | Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors | Wang P | 2021 Mar 01 |
|
33328334 | Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity | Vlach J | 2021 Mar |
|
33602388 | Postnatal cadmium administration affects the presence and distribution of carbohydrates in the sperm membrane during maturation in the epididymis in adult Wistar rats | Hernández-Rodríguez J | 2021 Mar |
|
33515704 | Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets | Bolanle IO | 2021 Mar |
|
33515675 | SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer | Yang C | 2021 Mar |
|
33864869 | Structural and functional analysis of the simultaneous binding of two duplex/quadruplex aptamers to human α-thrombin | Troisi R | 2021 Jun 30 |
|
34194039 | G-protein activation by a metabotropic glutamate receptor | Seven AB | 2021 Jun 30 |
|
34194040 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | Gao Y | 2021 Jun 30 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025